Bringing accuracy to image-guided procedures SIRIUS - Introducing the first Positive-Signal MRI Marker

C4 Imaging develops innovative medical devices that enable clinicians to personalize patient treatment through accurate image-guided procedures. The company’s core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has been encapsulated within an implantable, biocompatible shell.

C4 Imaging’s first product is the Sirius MRI Marker, which will be used to facilitate seed localization during the treatment of prostate cancer with radioactive seeds (brachytherapy). The Sirius MRI Marker will allow physicians to accurately locate seeds within the complicated anatomy of the prostate and the surrounding critical structures, utilizing a single post-implant MR imaging procedure. More...

Sirius… Turning Prostate Brachytherapy from an Art to a Science

Novel MRI Technology … Sirius; The First Implantable Positive-Signal MRI Marker